Zuellig's plan for 5,000 customer direct deals on progress

Published: 1999-07-16 10:18:00

Updated: 1999-07-16 10:18:00

KLS, a Korean legal business entity of Zuellig, seems to drive their drug distribution business plans from coming Sept., for which the KPA sensitively concerned and tried to prepare an appropriate action against the subordination possibility of the local drug distribution market to the foreign mu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK